Lipella Pharmaceuticals Inc.
LIPO- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347242
No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding LIPO, Q2 2026
No superinvestor reported holding LIPO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Lipella Pharmaceuticals Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 (view filing) | May 14 | 1 day | Kaufman Jonathan HSee remarks below. | PPurchase | +10.0K | $0.76 | +$7.60K | +1.1%898.8K after | |
| Mar 19, 2024 (view filing) | Mar 18-19 | 1 day | Kaufman Jonathan HSee remarks below. | PPurchase | +55.0K | $0.8264 | +$45.5K | +6.6%888.8K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Lipella Pharmaceuticals Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding LIPO in 13F filings for Q2 2026.